Search

Your search keyword '"Wendi Kuhnert"' showing total 3 results
Start Over Author "Wendi Kuhnert" Publisher centers for disease control and prevention
3 results on '"Wendi Kuhnert"'

1. Point-of-Care Antigen Test for SARS-CoV-2 in Asymptomatic College Students

Author

Sarah C. Tinker, Christine M. Szablewski, Anastasia P. Litvintseva, Cherie Drenzek, Gary E. Voccio, Melissa A. Hunter, Stephen Briggs, Debbie E. Heida, Jennifer Folster, Patricia L. Shewmaker, Magdalena Medrzycki, Michael D. Bowen, Caitlin Bohannon, Dennis Bagarozzi, Marla Petway, Paul A. Rota, Wendi Kuhnert-Tallman, Natalie Thornburg, Jessica L. Prince-Guerra, Lisa C. Barrios, Azaibi Tamin, Jennifer L. Harcourt, and Margaret A. Honein

Subjects
COVID-19, SARS-CoV-2, institutions of higher education, adolescents, young adults, antigen testing, Medicine, Infectious and parasitic diseases, RC109-216
Abstract

We used the BinaxNOW COVID-19 Ag Card to screen 1,540 asymptomatic college students for severe acute respiratory syndrome coronavirus 2 in a low-prevalence setting. Compared with reverse transcription PCR, BinaxNOW showed 20% overall sensitivity; among participants with culturable virus, sensitivity was 60%. BinaxNOW provides point-of-care screening but misses many infections.

Published
2021
Full Text
View/download PDF

2. SARS-CoV-2 Infections among Recent Organ Recipients, March–May 2020, United States

Author

Jefferson M. Jones, Ian Kracalik, Meenakshi M. Rana, Ann Nguyen, Brian C. Keller, Aaron Mishkin, Charles Hoopes, Thomas Kaleekal, Abhinav Humar, Juan Vilaro, Gene Im, Lou Smith, April Justice, Collette Leaumont, Stephen Lindstrom, Brett Whitaker, Ricardo M. La Hoz, Marian G. Michaels, David Klassen, Wendi Kuhnert, and Sridhar V. Basavaraju

Subjects
COVID-19, SARS-CoV-2, severe acute respiratory syndrome coronavirus 2, viruses, respiratory infections, zoonoses, Medicine, Infectious and parasitic diseases, RC109-216
Abstract

We conducted public health investigations of 8 organ transplant recipients who tested positive for severe acute respiratory syndrome coronavirus 2 infection. Findings suggest the most likely source of transmission was community or healthcare exposure, not the organ donor. Transplant centers should educate transplant candidates and recipients about infection prevention recommendations.

Published
2021
Full Text
View/download PDF

3. Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing

Author

Sarah E, Smith-Jeffcoat, Mitsuki, Koh, Adam, Hoffman, Paulina A, Rebolledo, Marcos C, Schechter, Halie K, Miller, Sadia, Sleweon, Rebecca, Rossetti, Vyjayanti, Kasinathan, Talya, Shragai, Kevin, O'Laughlin, Catherine C, Espinosa, George M, Khalil, AdeSubomi O, Adeyemo, Anne, Moorman, Brenda L, Bauman, Kahaliah, Joseph, Michelle, O'Hegarty, Nazia, Kamal, Hany, Atallah, Brooks L, Moore, Caitlin D, Bohannon, Bettina, Bankamp, Claire, Hartloge, Michael D, Bowen, Ashley, Paulick, Amy S, Gargis, Christopher, Elkins, Rebekah J, Stewart, Juliana, da Silva, Caitlin, Biedron, Jacqueline E, Tate, Yun F, Wang, Hannah L, Kirking, and Wendi, Kuhnert-Tallman

Subjects
Microbiology (medical), Male, 2019-20 coronavirus outbreak, medicine.medical_specialty, Saliva, Georgia, Coronavirus disease 2019 (COVID-19), Epidemiology, Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), coronaviruses, Patient characteristics, Infectious and parasitic diseases, RC109-216, anterior nasal, Specimen Handling, 2019 novel coronavirus disease, respiratory infections, COVID-19 Testing, Internal medicine, Nasopharynx, medicine, Humans, viruses, Symptom onset, Aged, 80 and over, saliva, business.industry, SARS-CoV-2, Research, COVID-19, sensitivity, United States, zoonoses, Infectious Diseases, coronavirus disease, self-collected, Nasal Swab, Medicine, business, Effects of Patient Characteristics on Diagnostic Performance of Self-Collected Samples for SARS-CoV-2 Testing, severe acute respiratory syndrome coronavirus 2
Abstract

We evaluated the performance of self-collected anterior nasal swab (ANS) and saliva samples compared with healthcare worker-collected nasopharyngeal swab specimens used to test for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). We used the same PCR diagnostic panel to test all self-collected and healthcare worker-collected samples from participants at a public hospital in Atlanta, Georgia, USA. Among 1,076 participants, 51.9% were men, 57.1% were >50 years of age, 81.2% were Black (non-Hispanic), and 74.9% reported >1 chronic medical condition. In total, 8.0% tested positive for SARS-CoV-2. Compared with nasopharyngeal swab samples, ANS samples had a sensitivity of 59% and saliva samples a sensitivity of 68%. Among participants tested 3-7 days after symptom onset, ANS samples had a sensitivity of 80% and saliva samples a sensitivity of 85%. Sensitivity varied by specimen type and patient characteristics. These findings can help physicians interpret PCR results for SARS-CoV-2.

Published
2021

Catalog

Books, media, physical & digital resources
See catalog results